St. Louis, Missouri – November 30, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Heart Research Institute (HRI).

Scientists at HRI will use Partek to analyze gene expression data generated from studies about the effects of sex hormones in heart disease and the link between diabetic kidney disease and heart disease. HRI is Australia’s leading institute for atherosclerosis research and was founded in 1989. HRI is located in New South Wales.

Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.